24. Analysis of indoleamine 2,3-dioxygenase expression in longitudinal primary, nodal and distant metastatic melanoma specimens

Tuba N. Gide; Benjamin Allanson; Peter M. Ferguson; Alexander M. Menzies; Robyn P.M. Saw; John F. Thompson; Georgina V. Long; Richard A Scolyer; James S. Wilmott

doi:10.1016/j.pathol.2018.09.024

Back

24. Analysis of indoleamine 2,3-dioxygenase expression in longitudinal primary, nodal and distant metastatic melanoma specimens

Article 2019 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2018

Inter‐ and intrapatient heterogeneity of indoleamine 2,3‐dioxygenase expression in primary and metastatic melanoma cells and the tumour microenvironment

Tuba N. Gide, Benjamin Allanson, Alexander M. Menzies, Peter M. Ferguson, Jason Madore, Robyn P.M. Saw, John F. Thompson, Georgina V. Long, James S. Wilmott, Richard A Scolyer

Article2010

Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease

David Bonda, Maneesh Mailankot, Jeremy Stone, Matthew R. Garrett, Magdalena Staniszewska, Rudy J. Castellani, Sandra L. Siedlak, Xiongwei Zhu, Hyoung‐gon Lee, George Perry, Ram H. Nagaraj, Mark A. Smith

Article2004

The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression.

Marieke Wichers, Michael Maes

Article2004

The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-α-induced depression

Marieke Wichers, Michael Maes

Article2012

Decreased indoleamine 2,3-dioxygenase activity and IL-10/IL-17A ratio in patients with COPD

Kittipong Maneechotesuwan, Kanda Kasetsinsombat, Adisak Wongkajornsilp, Peter J Barnes